Verdict: Direct comparison difficult due to different trial designs, but retatrutide's advantage appears substantial even accounting for flexible vs fixed dosing
A research label, supplier statement or lack of medicinal approval does not remove anti-doping consequences
It does become very hard when you already have this Amazon beast, which has that infrastructure built, already has plans to do this bargain retail segment to react to Timo and Sheen
Unlike endogenous GLP-1, which is rapidly degraded by dipeptidyl peptidase-4, GLP-1 receptor agonists are resistant to degradation and have longer half-lives, particularly for modern long-acting agents, such as liraglutide, dulaglutide, semaglutide and tirzepatide
Further research is required to gain a more comprehensive understanding of this aspect